Pharmaceutical Granules and their Applications in Drug Formulations
Pharmaceutical granules are dry, solid, aggregated particles typically composed of active pharmaceutical ingredients (APIs) and excipients together in a mixture form. Granules are often prepared by processes like wet granulation, dry granulation, and fluid bed granulation. They offer a convenient and functional intermediate for a range of drug formulations.
Granules have seen a surge in popularity in recent years due to their versatile applications, patient-friendly drug release profiles, and manufacturing advantages. Pharmaceutical granules offer better flow properties and uniformity compared to powders, making them easier to process during commercial manufacturing.
For patients especially pediatrics and geriatrics, drug granules are often preferred because they can be easily administered with water or food, and customized for taste-masking as taste-masked granules.
Additionally, granule formulations allow for immediate, extended, modified, or controlled drug release, aligning with the growing interest in patient-centric and advanced drug delivery systems.
Some of the applications of pharmaceutical granules are presented below:
- Oral Dosage Forms: Pharmaceutical granules can be used to create tablets, capsules, and sachet formulations.
- Granules are often compressed into tablets or filled into capsules (immediate release or sustained release) to ensure accurate dosing and better mechanical properties. Drug granules can also be reconstituted with water just before administration in the form of dry syrup preparations, commonly seen in pediatric formulations.
- Modified Drug Release: Granules can be formulated as immediate release, extended release, delayed release, sustained release, or controlled release formulations.
- Improved Flowability & Enhanced Compressibility: Granules flow more easily than powders, aiding in uniform filling during manufacturing. Granules are often compressed into tablets whether immediate release or sustained release with better uniformity and mechanical strength.
- Taste Masking and Stability: Granulation can help mask unpleasant taste and improve the chemical stability of sensitive ingredients. Granules can also be flavored and sweetened for pediatric and geriatric patients.
Granulation Techniques in Pharmaceutical Production
Granule manufacturing in the pharmaceutical industry primarily uses three common granulation techniques: wet granulation, dry granulation, and fluid bed granulation, with some specialized methods like spray drying and melt granulation used in specific cases.
- Wet Granulation: Among all the granulation techniques, wet granulation is the most common approach. It involves mixing APIs with excipients in powder form with a liquid binder to form a moist mass, which is then sieved into drug granules, dried, and screened. This wet granulation technique is suitable for ingredients that can tolerate moisture and heat.
Wet granulation also improves the flowability, compressibility, and content uniformity of powders, making it suitable for most tablet and capsule formulations.
- Dry granulation: This granulation technique is used when the drug is heat- or moisture-sensitive. It does not require any liquid. Instead, powders are compacted under high pressure to form slugs or ribbons, which are then milled into drug granules.
The dry granulation technique is simpler and more economical but may result in pharmaceutical granules with less uniformity compared to wet granulation.
- Fluid bed granulation: It is a variation of wet granulation that combines mixing, granulating, and drying in one chamber. Fluidized bed granulation suspends powders in an air stream while spraying a binder solution. Drug Granules form as the binder droplets coat and agglomerate particles.
Fluid bed granulation ensures uniformity and is scalable for industrial use.
- Spray Drying: Other specialized granulation techniques include spray drying, which takes a solution or suspension of the drug and atomizes it into a hot air stream. The solvent rapidly evaporates, leaving behind dry granules, which is ideal for highly soluble drugs or inhalation products.
- Melt granulation: On the other hand, melt granulation uses thermoplastic binders that melt during processing and solidify upon cooling, offering an alternative solvent-free approach, often used in sustained-release granules.
The choice of granulation technique depends on various factors such as the physicochemical properties of the drug, manufacturing considerations and desired release profile for drug delivery, whether it would be sustained release, immediate release, extended release, delayed release or controlled release.
Sustained vs. Immediate Release Granules – Drug Delivery Perspectives
The demand for immediate and sustained release granules is growing steadily, driven by the need for more effective and patient-friendly drug delivery systems.
This rapid onset of action by immediate release granules and controlled and prolonged therapeutic effect by sustained release granules support both acute and chronic treatment needs, making granule formulations highly attractive for pharmaceutical companies targeting diverse therapeutic areas.
The key difference between sustained-release and immediate-release granules lies in how quickly the drug is released and absorbed into the body after administration.
Immediate-release (IR) granules are designed to dissolve quickly once ingested, releasing the API immediately into the gastrointestinal tract. This leads to rapid absorption and quick onset of therapeutic action.
Immediate-release granules are designed for rapid dissolution and quick absorption. These drug granules deliver the full dose shortly after administration.
In contrast, sustained-release (SR) granules are formulated to release the drug slowly and steadily over an extended period of time. This sustained release allows for a more consistent concentration of the drug in the bloodstream, potentially reducing the number of doses needed per day and minimizing fluctuations in therapeutic levels as well as side effects.
Sustained-release (SR) granules often use special coatings, matrix systems, or polymers to regulate the release rate of the drug
Gangwal Healthcare’s Expertise in Advanced Granule Formulations
Gangwal Healthcare is considered a leading pharmaceutical manufacturer and supplier of granules and pellets due to its strong foundation in innovation, quality, and specialized formulation expertise.
With over four decades of experience in the pharmaceutical industries, Gangwal Healthcare has built a reputation for delivering high-quality, customized granule formulations that meet global regulatory standards.
One of the key strengths of Gangwal Healthcare lies in its technological capabilities and advanced pharmaceutical manufacturing infrastructure, which support a wide range of pharmaceutical granule types, including immediate-release granules, sustained-release granules, effervescent granules, and taste-masked granules.
Directly Compressible (DC) Granules are another key offering of Gangwal which are pre-processed drug granules specifically engineered for direct compression into tablets without the need for additional granulation steps.
These DC granules offer excellent flowability, uniformity, and compressibility, making them ideal for high-speed tablet manufacturing. DC granules reduce production time and enhance batch-to-batch consistency, making them a preferred choice in modern pharmaceutical manufacturing.
Gangwal Healthcare’s capability to offer customized DC granules supports rapid scale-up and efficient formulation development for both generic and branded products.
The company employs both wet granulation and dry granulation techniques, along with fluid bed processing and various coating technologies, to meet diverse therapeutic, extended and sustained-release profiles.
Gangwal also distinguishes itself through a strong focus on research and development, enabling the creation of innovative, patient-centric granule and pellet semi-finished formulations that improve drug stability, bioavailability, and compliance.
Additionally, Gangwal Healthcare’s global reach, coupled with its ability to offer pharmaceutical customized solutions for both branded and generic markets, makes it a preferred pharmaceutical partner for the manufacturing of immediate-release and sustained-release granules and pellets around the world.
This blend of experience, technological strength, regulatory compliance, and customer-focused innovation underpins its leadership in granule and pellet manufacturing.
